Literature DB >> 10573271

Serum sickness-like reaction with bupropion.

P M Peloso, C Baillie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10573271     DOI： 10.1001/jama.282.19.1817

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Serum sickness-like reaction associated with clopidogrel.

Authors:  Elizabeth J Phillips; Sandra R Knowles; Neil H Shear
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

Review 2.  Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.

Authors:  J Taylor Hays; Jon O Ebbert
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

Review 3.  Tolerability and safety of sustained-release bupropion in the management of smoking cessation.

Authors:  Henri-Jean Aubin
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004.

Authors:  Marie-Nöelle Beyens; Claire Guy; Genevieve Mounier; Sylvie Laporte; Michel Ollagnier
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 5.  Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits.

Authors:  J Taylor Hays; Jon O Ebbert
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

6.  Delayed onset urticaria in depressive patients with bupropion prescription: a nationwide population-based study.

Authors:  Li-Yu Hu; Chia-Jen Liu; Ti Lu; Tsung-Ming Hu; Chia-Fen Tsai; Yu-Wen Hu; Cheng-Che Shen; Yu-Sheng Chang; Mu-Hong Chen; Chung-Jen Teng; Huey-Ling Chiang; Chiu-Mei Yeh; Vincent Yi-Fong Su; Wei-Shu Wang; Pan-Ming Chen; Tzeng-Ji Chen; Tung-Ping Su
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.